Aimed Bio Inc. (KOSDAQ:0009K0)
21,350
-650 (-2.95%)
At close: Oct 22, 2026
Aimed Bio Revenue
Aimed Bio had revenue of 20.20B KRW in the quarter ending June 30, 2026, with 165.61% growth. This brings the company's total for the last twelve months to 66.79B, up 222.57% year-over-year. In the year 2025, Aimed Bio had annual revenue of 47.28B with 302.02% growth. That makes Aimed Bio the 27,988th largest company in the world by revenue and 1,700th in South Korea.
Revenue (ttm)
66.79B
Revenue Growth
+222.57%
P/S Ratio
20.67
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.38T
Revenue by Geography
- Overseas 43.54B 92.1%
- South Korea 3.74B 7.9%
Fiscal year ended Dec 31, 2025 See the full Aimed Bio breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 47.28B | 35.52B | 302.02% |
| Dec 31, 2024 | 11.76B | 11.59B | 6,768.70% |
| Dec 31, 2023 | 171.21M | 60.12M | 54.11% |
| Dec 31, 2022 | 111.09M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.